GL1X · GenesisL1 explorer

MolNFT v1 · #23041 · protein

Crystal structure of the complex of subtilisin bpn' with chymotrypsin inhibitor 2 Y61A mutant

1TO1: “Crystal structure of the complex of subtilisin bpn' with chymotrypsin inhibitor 2 Y61A mutant”. X-ray diffraction, 2 ligands (CA, NA), 1 pocket (best druggability 0.61). MolNFT v1 #23041 on GenesisL1: 3D structure, binding sites and…

PDB
1TO1
Type
protein
Length
344 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Subtilisin bpn'; Chymotrypsin inhibitor 2
EC
3.4.21.62
UniProt
P00782, Q40059
Ligands
CA, NA
Pockets
1 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 28% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ESubtilisin bpn' (EC 3.4.21.62)protein28129% helix, 22% strandP00782
IChymotrypsin inhibitor 2protein6322% helix, 35% strandQ40059

Ligands and binding sites

  • CA · Calcium ion · metal · chains E
  • NA · Sodium ion · metal · chains E
  • 1PE · Pentaethylene glycol · additive · 4 copies · chains E, I
  • CIT · Citric acid · additive · 2 copies · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12090.610.8239empty

Interfaces

1 interface between chains.

  • E–I · 786 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 1TO1 · crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 Y61A… · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.